View of Current experience with treatment of prognostically unfavorable acute myeloid leukemias with CPX-351 at the Institute of Hematology and Blood Transfusion

Return to Issue Details Current experience with treatment of prognostically unfavorable acute myeloid leukemias with CPX-351 at the Institute of Hematology and Blood Transfusion Download Download PDF